Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders. - Wikidata - awgldk - TriplyDB

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

http://www.wikidata.org/entity/Q37103046

about

Neuroprotective Effects Against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton Neurologic effects of exogenous saccharides: a review of controlled human, animal, and in vitro studies Proteoglycans in the central nervous system: role in development, neural repair, and Alzheimer's disease Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.Heparin binding confers prion stability and impairs its aggregation.Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin.Self-evolving oxidative stress with identifiable pre- and postmitochondrial phases in PC12 cells.Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy.Inhibiting, promoting, and preserving stability of functional proteinfibrils

P2860

Q26768713-3A9B7349-C277-430E-ADFB-3F1E6B578FAD Q26823883-22D29EA4-788B-45EC-B2BE-53E7639C699D Q26865932-AA0DACAF-D51A-4AA8-A141-5D671F592F44 Q33389069-1298BE56-89D0-4156-BC1B-B44FA209F08B Q33613234-CF3CF866-98D9-4E11-ABBA-C1ECAADC891C Q42319844-8AC63E7F-AC92-439D-AEBC-815054C34C3D Q46202002-9A3BAA8E-49D1-46FE-93E0-63C35A200653 Q52641483-4EEBA93D-27CC-4D54-BB0A-FB18024467A2 Q57364071-4BF22F1B-F571-4B77-8252-6A6DB6BEAE7E

P2860

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

http://www.wikidata.org/entity/Q37103046

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neuroprotective properties of ...... r neurodegenerative disorders.

@en

Neuroprotective properties of ...... r neurodegenerative disorders.

@nl

type

label

Neuroprotective properties of ...... r neurodegenerative disorders.

@en

Neuroprotective properties of ...... r neurodegenerative disorders.

@nl

prefLabel

Neuroprotective properties of ...... r neurodegenerative disorders.

@en

Neuroprotective properties of ...... r neurodegenerative disorders.

@nl

P1433

Q37103046-235EC66C-DC6C-4961-B7C8-D4000893C843

P1476

Q37103046-7D4A2673-4F6A-4E43-A00B-83BE0259963E

P2093

Q37103046-0EE1508A-30E9-40C8-97B3-2B22600DAED5

Q37103046-2E213808-ADF8-4A32-BCF8-4859FF9DB579

Q37103046-A935AAB6-8146-4A9F-BFA2-5D4D078B3342

Q37103046-D60187B7-837C-4425-B627-596FF92DAC8B

Q37103046-EBCFA62B-A0EC-4385-80A6-46123C6CBA13

P2860

Q37103046-04FA376F-AA76-4665-B336-59F42436979B

Q37103046-19C3D926-7097-45E0-BFA3-1C9DA2297661

Q37103046-21276504-C3E6-411B-9CCA-1CA346D7D07B

Q37103046-32EDFA07-58F8-4D60-8BD1-5AAA2D947B5C

Q37103046-377DD300-5279-4DC2-B82E-032C322C1509

Q37103046-385A2619-6640-4807-B307-8CFE3DA4D235

Q37103046-4608E340-DED7-4AC9-B3B5-45A05B9FDD5B

Q37103046-4C18B78F-986E-4312-A0A7-2A5C1BF946BB

Q37103046-66897A1E-C0DE-443B-BFFA-653971F20414

Q37103046-6D334288-F52E-4192-94F0-4A0D31AD6409

P304

Q37103046-E50B4A82-6DB6-45E7-9360-B99C90AD70FF

P31

Q37103046-37659005-9558-4AAD-AAD1-9A2FB1365062

P356

Q37103046-DAC68EE6-7FF3-4E34-9C7B-D6A44924DD90

P433

Q37103046-7CDD37BC-7567-4EB9-9CF9-06AE4B35FABC

P478

Q37103046-47D521E1-C54C-47DC-8979-C8249156C197

P577

Q37103046-865834A0-8590-4D4D-9325-5ABEE271614B

P5875

Q37103046-F18C774E-42E9-4031-A4EF-D48566C7A1B4

P698

Q37103046-2B8AA8B0-5AFD-433F-BA02-F570FFF1E9F0

P921

Q37103046-62845204-C797-4C18-BBE5-6A1505080E4B

P932

Q37103046-EFD13733-E4B2-44F8-BE62-8114D7DF58DB

P356

P1433

Neurodegenerative Diseases

P1476

Neuroprotective properties of ...... r neurodegenerative disorders.

@en

P2093

A Pavlovich

http://www.w3.org/2001/XMLSchema#string

B Dudas

http://www.w3.org/2001/XMLSchema#string

I Hanin

http://www.w3.org/2001/XMLSchema#string

M Rose

http://www.w3.org/2001/XMLSchema#string

U Cornelli

http://www.w3.org/2001/XMLSchema#string

P2860

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

Inhibition of glomerular cell apoptosis by heparin

Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death.

Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease.

Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells.

Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system.

Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide.

Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin.

Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma.

P304

200-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000113702

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5530755

http://www.w3.org/2001/XMLSchema#string

P698

18322390

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

2826452

http://www.w3.org/2001/XMLSchema#string